Clinical Study

Radiographic Parameters in Predicting Outcome of Patients with Hepatocellular Carcinoma Treated with Yttrium-90 Microsphere Radioembolization

Table 4

Response of hepatocellular carcinoma to treatment with selective internal radiotherapy with Yttrium-90 microspheres*.

Response criteriaNo. (%) patients

RECIST
 Partial response2 (10%)0.09
 Stable disease17 (80%)
 Progressive disease2 (10%)
MASS criteria
 Favorable response4 (44%)0.027
 Indeterminate response2 (22%)
 Unfavorable response3 (33%)

log-rank test; association of response criteria with overall survival.
RECIST: response evaluation criteria in solid tumors; patients.
MASS: morphology, attenuation, size, and structure; patients.